99mTc-labelled HYNIC-minigastrin with reduced kidney uptake for targeting of CCK-2 receptor-positive tumours
- 17 February 2007
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 34 (8), 1209-1218
- https://doi.org/10.1007/s00259-006-0348-3
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- 99mTc-Labeling and in Vitro and in Vivo Evaluation of HYNIC- and (Nα-His)Acetic Acid-Modified [d-Glu1]-MinigastrinBioconjugate Chemistry, 2004
- Two Technetium-99m-Labeled Cholecystokinin-8 (CCK8) Peptides for Scintigraphic Imaging of CCK ReceptorsBioconjugate Chemistry, 2004
- Imaging Lung Tumors with Peptide-Based RadioligandsClinical Lung Cancer, 2003
- Improved kinetic stability of DTPA-dGlu as compared with conventional monofunctional DTPA in chelating indium and yttrium: preclinical and initial clinical evaluation of radiometal labelled minigastrin derivativesEuropean Journal of Nuclear Medicine and Molecular Imaging, 2003
- Preparation via coligand exchange and characterization of [99mTc-EDDA-HYNIC-D-Phe1,Tyr3]Octreotide (99mTc-EDDA/HYNIC-TOC)Journal of Labelled Compounds and Radiopharmaceuticals, 2003
- Infection is not specific for bacterial osteo-articular infective pathologyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2003
- Cholecystokinin-B/gastrin receptor-targeting peptides for staging and therapy of medullary thyroid cancer and other cholecystokinin-B receptor-expressing malignanciesSeminars in Nuclear Medicine, 2002
- Cholecystokinin‐B (CCK‐B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK‐B receptor expressing malignanciesPeptide Science, 2002
- Radiolabeling approaches for cholecystokinin B receptor imagingPeptide Science, 2002
- Neuroendocrine gastrointestinal tumoursAnnals Of Oncology, 1996